AU4269401A - HCV NS2/3 fragments and uses thereof - Google Patents

HCV NS2/3 fragments and uses thereof

Info

Publication number
AU4269401A
AU4269401A AU42694/01A AU4269401A AU4269401A AU 4269401 A AU4269401 A AU 4269401A AU 42694/01 A AU42694/01 A AU 42694/01A AU 4269401 A AU4269401 A AU 4269401A AU 4269401 A AU4269401 A AU 4269401A
Authority
AU
Australia
Prior art keywords
hcv
fragments
renatured
modulators
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42694/01A
Other languages
English (en)
Inventor
Armin Lahm
Michele Pallaoro
Christian Steinkuhler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Publication of AU4269401A publication Critical patent/AU4269401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Hydrogenated Pyridines (AREA)
  • Detergent Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU42694/01A 2000-03-17 2001-03-14 HCV NS2/3 fragments and uses thereof Abandoned AU4269401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0006537.5A GB0006537D0 (en) 2000-03-17 2000-03-17 Assays and screening methods
GB0006537 2000-03-17
PCT/IB2001/000527 WO2001068818A2 (en) 2000-03-17 2001-03-14 Hcv ns2/3 fragments and uses thereof

Publications (1)

Publication Number Publication Date
AU4269401A true AU4269401A (en) 2001-09-24

Family

ID=9887885

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42694/01A Abandoned AU4269401A (en) 2000-03-17 2001-03-14 HCV NS2/3 fragments and uses thereof

Country Status (10)

Country Link
US (1) US7078215B2 (enExample)
EP (1) EP1278867B1 (enExample)
JP (1) JP2003526361A (enExample)
AT (1) ATE315093T1 (enExample)
AU (1) AU4269401A (enExample)
CA (1) CA2403405A1 (enExample)
DE (1) DE60116474T2 (enExample)
ES (1) ES2254380T3 (enExample)
GB (1) GB0006537D0 (enExample)
WO (1) WO2001068818A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3878132B2 (ja) 2000-12-15 2007-02-07 ベーリンガー インゲルハイム （カナダ） リミテッド 精製活性型ｈｃｖｎｓ２／３プロテアーゼ
DE60304435T2 (de) * 2004-01-19 2006-08-24 Ares Trading S.A. Verfahren zur Reinigung von in Bakterien exprimierten Proteinen
US20090233266A1 (en) * 2005-03-10 2009-09-17 The Rockefeller University Structure of the hepatitis c virus ns2 protein
ES2386462T3 (es) * 2005-10-28 2012-08-21 Boehringer Ingelheim International Gmbh Ensayo de la actividad NS2/3 del virus de la hepatitis C
EP2388312A1 (en) 2010-05-17 2011-11-23 Curetis AG Universally applicable lysis buffer and processing methods for the lysis of bodily samples

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
IT1277914B1 (it) 1995-08-22 1997-11-12 Angeletti P Ist Richerche Bio Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
US5837464A (en) * 1996-01-29 1998-11-17 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
CA2383411A1 (en) * 1999-08-30 2001-03-08 Paul L. Darke Hepatitis c virus replication inhibitors
JP3878132B2 (ja) * 2000-12-15 2007-02-07 ベーリンガー インゲルハイム （カナダ） リミテッド 精製活性型ｈｃｖｎｓ２／３プロテアーゼ

Also Published As

Publication number Publication date
ATE315093T1 (de) 2006-02-15
US7078215B2 (en) 2006-07-18
WO2001068818A2 (en) 2001-09-20
DE60116474D1 (de) 2006-03-30
GB0006537D0 (en) 2000-05-10
DE60116474T2 (de) 2006-09-07
JP2003526361A (ja) 2003-09-09
CA2403405A1 (en) 2001-09-20
US20040054134A1 (en) 2004-03-18
ES2254380T3 (es) 2006-06-16
EP1278867B1 (en) 2006-01-04
WO2001068818A3 (en) 2002-03-21
EP1278867A2 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
IT1272179B (it) Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.
AU7991300A (en) Membrane type serine protease 1 (mt-sp1) and uses thereof
DE60131262D1 (en) Ubiquitin-ligase-assay
AU2001247788A1 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor
AU144678S (en) Bottle
AU2002252856A1 (en) Expression of core-glycosylated hcv envelope proteins in yeast
AU2002325758A1 (en) Cultured stromal cells and uses thereof
WO2002018546A3 (en) Plasma-derived-fibrin-based matrices and tissue
CA98278S (en) Bottle
AU5340399A (en) Proteases and associated proteins
WO2000063247A3 (en) Osteopontin-derived chemotactic and inhibitory agents and uses therefor
WO2001068818A3 (en) Hcv ns2/3 fragments and uses thereof
DK1551361T3 (da) Oral sammensætning med forbedrede mundhygiejneegenskaber
ATE326520T1 (de) Teilchen für flüssige zubereitungen
CA98279S (en) Bottle
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
AU2002354560A1 (en) Targeted fusion proteins and methods for the characterization of cellular membrane domains
AU6509898A (en) Activation of peptides
WO2001058954A3 (en) Trade molecules and uses related thereto
GB0005326D0 (en) Enzymes and uses relating thereto
AU2002229850A1 (en) Polypeptide inducing hiv-neutralising antibodies
AU2001296780A1 (en) 48120, 23479, and 46689, novel human hydrolases and uses thereof
AU2001295778A1 (en) Novel cysteine proteases and uses thereof
AU2003296820A1 (en) Epitopic peptides of the thyroperoxidase enzyme, compositions containing same and uses thereof
AU2001253907A1 (en) 27960, a novel ubiquitin conjugating enzyme family member and uses therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase